Corrigendum: Acute Administration of Metformin Protects Against Neuronal Apoptosis Induced by Cerebral Ischemia-Reperfusion Injury via Regulation of the AMPK/CREB/BDNF Pathway

Affiliations

¹ Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
² Department of Neurology, People's Hospital of Zhengzhou, People's Hospital of Henan University of Chinese Medicine, Zhengzhou, China.

Published Erratum

Ke Liu et al. Front Pharmacol. 2022.

. 2022 Jun 2:13:929835.

doi: 10.3389/fphar.2022.929835. eCollection 2022.

¹ Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
² Department of Neurology, People's Hospital of Zhengzhou, People's Hospital of Henan University of Chinese Medicine, Zhengzhou, China.

Abstract

[This corrects the article DOI: 10.3389/fphar.2022.832611.].

Keywords: AMP-activated protein kinase; brain-derived neurotrophic factor; cerebral ischemia-reperfusion injury; metformin; neuronal apoptosis.

Acute Administration of Metformin Protects Against Neuronal Apoptosis Induced by Cerebral Ischemia-Reperfusion Injury via Regulation of the AMPK/CREB/BDNF Pathway.
Liu K, Li L, Liu Z, Li G, Wu Y, Jiang X, Wang M, Chang Y, Jiang T, Luo J, Zhu J, Li H, Wang Y. Liu K, et al. Front Pharmacol. 2022 Apr 1;13:832611. doi: 10.3389/fphar.2022.832611. eCollection 2022. Front Pharmacol. 2022. PMID: 35431946 Free PMC article.